Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells [Phase 2]
A Phase 2 clinical trial evaluating allogeneic mesenchymal stem cells for lupus nephritis, currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
Clinical trial update describing the EACVI study on multimodality cardiovascular imaging for inflammatory cardiovascular diseases, with myoc…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: REACH (Restore Energy, Activity Can Help) Lupus Study [NA]
This document provides a status update on the REACH lupus study sponsored by Tufts Medical Center; the trial targets systemic lupus erythema…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: A Study of CAR-T Cells in Subjects With Systemic Lupus Erythematosus [NA]
The entry describes a clinical trial investigating CAR-T cell therapy for systemic lupus erythematosus, with status NOT_YET_RECRUITING.
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Role of Musculoskeletal Ultrasound for Early Detection of Synovitis in SLE Patient and Its Correlation With Disease Activity and Neutrophil-to-C3 Ratio.
The study investigates whether musculoskeletal ultrasound can detect synovitis early in systemic lupus erythematosus patients. It also exami…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial evaluating YTS109 cell therapy for relapsed/refractory autoimmune diseases is currently recruiting. The study cover…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Vunakizumab for the Treatment of Mild to Moderate Systemic Lupus Erythematosus [Phase 1]
A Phase 1 clinical trial of Vunakizumab for mild to moderate systemic lupus erythematosus is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Systemic Lupus Erythematosus in Gullah Health
This clinical trial update notes a study on Systemic Lupus Erythematosus at the Medical University of South Carolina that is currently recru…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: AGR+PNI as Predictors of Systemic Lupus Erythematosus Disease Activity
This ClinicalTrials.gov entry describes a study investigating AGR+PNI as predictors of disease activity in systemic lupus erythematosus, wit…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Treatment of Systemic Lupus Erythematosus With Human Umbilical Cord Mesenchymal Stem Cells [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating human umbilical cord mesenchymal stem cells for systemic lupus erythematosus. The study is currentl…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: AZAHAR Study To Describe Anifrolumab in a Real-World Setting
An observational real-world study update detailing the use of Anifrolumab in systemic lupus erythematosus (SLE) from the AZAHAR study. The s…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Systemic Lupus Erythematosus [Phase 1]
An ongoing Phase 1 clinical trial evaluating GNC-038, a tetra-specific antibody, in patients with systemic lupus erythematosus, sponsored by…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Correlation Between Serum Uric Acid, Serum Homocysteine Level and Interleukin- 17 in Lupus Nephritis Patients
A recruiting clinical trial examining the relationships between serum uric acid, serum homocysteine, and interleukin-17 levels in patients w…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) [Phase 2]
A Phase 2 study is evaluating Afimetoran versus placebo in active systemic lupus erythematosus, with the trial currently active but not recr…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Belimumab (BENLYSTA®) Pregnancy Registry
Clinical trial update reporting on the completed pregnancy registry for belimumab (BENLYSTA) in patients with systemic lupus erythematosus.
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: The Frequency of Thiopurine Methyltransferase Polymorphism in Systemic Lupus Erythematosus SLE
The completed trial investigated how common thiopurine methyltransferase (TPMT) genetic polymorphisms are among patients with systemic lupus…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Fatigue in Lupus Intervention Programmes (FLIP) [NA]
A clinical trial update for the Fatigue in Lupus Intervention Programmes (FLIP) evaluating fatigue management in systemic lupus erythematosu…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress [NA]
Clinical trial status update about teams developing accessible mental health interventions for lupus erythematosus and dermatomyositis; the …
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Long-Term Outcomes in SLE at Peking University People's Hospital
A long-term outcomes study of systemic lupus erythematosus being conducted at Peking University People's Hospital; the trial is currently re…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: A Phase Ib Study of QLS4131 in Subjects With Systemic Lupus Erythematosus [Phase 1]
This document reports an early-phase (Phase Ib) trial of QLS4131 for systemic lupus erythematosus. The study is listed as not yet recruiting…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Occupational and Environmental Causes of Autoimmune Diseases [NA]
A clinical trial update indicates a study examining occupational and environmental factors in autoimmune diseases has completed. Conditions …
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus [Phase 1]
This clinical trial update reports a Phase 1 study evaluating BAFF CAR-T cells (LMY-920) for systemic lupus erythematosus, currently recruit…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults
This clinical trial update notes ongoing recruitment for a longitudinal follow-up study of newly diagnosed polyarthritis in children and you…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis [Phase 1]
A Phase 1 clinical trial evaluating NK010 or NK042 in combination with Rituximab for refractory systemic lupus erythematosus and refractory …
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases [Phase 1]
A Phase 1 study evaluating OL-108 in relapsed/refractory autoimmune diseases is currently recruiting, including systemic lupus erythematosus…